These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 28574932)

  • 1. Vascular Endothelial Growth Factor (VEGF) Polymorphisms and Serum VEGF Levels in Women With Epithelial Ovarian Cancer, Benign Tumors, and Healthy Ovaries.
    González-Palomares B; Coronado Martín PJ; Maestro de Las Casas ML; Veganzones de Castro S; Rafael Fernández S; Vidaurreta Lázaro M; De la Orden García V; Vidart Aragon JA
    Int J Gynecol Cancer; 2017 Jul; 27(6):1088-1095. PubMed ID: 28574932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship of VEGF polymorphisms with serum VEGF levels and progression-free survival in patients with epithelial ovarian cancer.
    Steffensen KD; Waldstrøm M; Brandslund I; Jakobsen A
    Gynecol Oncol; 2010 Apr; 117(1):109-16. PubMed ID: 20056267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular endothelial growth factor polymorphisms and a synchronized examination of plasma and tissue expression in epithelial ovarian cancers.
    Bhaskari J; Premalata CS; Shilpa V; Rahul B; Pallavi VR; Ramesh G; Krishnamoorthy L
    Tumour Biol; 2016 Jan; 37(1):1017-23. PubMed ID: 26264619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum Vascular Endothelial Growth Factor-A as a Prognostic Biomarker for Epithelial Ovarian Cancer.
    Komatsu H; Oishi T; Itamochi H; Shimada M; Sato S; Chikumi J; Sato S; Nonaka M; Sawada M; Wakahara M; Umekita Y; Harada T
    Int J Gynecol Cancer; 2017 Sep; 27(7):1325-1332. PubMed ID: 28557832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression and significance of VEGF, miR-205 and target protein Ezrin and Lamin A/C in ovarian cancer].
    Zhou J; Liu H; Chen Y; Wen J; Li L; Wu X
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2014 Feb; 39(2):142-50. PubMed ID: 24608381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigating impact of Vascular Endothelial Growth Factor Polymorphisms in Epithelial Ovarian Cancers: A Study in the Indian Population.
    Janardhan B; Vaderhobli S; Bhagat R; Chennagiri Srinivasamurthy P; Venketeshiah Reddihalli P; Gawari R; Krishnamoorthy L
    PLoS One; 2015; 10(7):e0131190. PubMed ID: 26158818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VEGF gene polymorphisms and outcome of epithelial ovarian cancer patients.
    Camerin GR; Brito AB; Vassallo J; Derchain SF; Lima CS
    Future Oncol; 2017 Feb; 13(5):409-414. PubMed ID: 27780361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular matrix metalloproteinase inducer (EMMPRIN) expression correlates positively with active angiogenesis and negatively with basic fibroblast growth factor expression in epithelial ovarian cancer.
    Szubert S; Szpurek D; Moszynski R; Nowicki M; Frankowski A; Sajdak S; Michalak S
    J Cancer Res Clin Oncol; 2014 Mar; 140(3):361-9. PubMed ID: 24374756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Serum level and expression of vascular epithelial growth factor in ovarian epithelial carcinoma].
    Sun LX; Wu Y; Han HQ; Wang QH
    Ai Zheng; 2003 Jan; 22(1):58-61. PubMed ID: 12561438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of vascular endothelial growth factor (VEGF) gene polymorphism and increased serum VEGF concentration with pancreatic adenocarcinoma.
    Sivaprasad S; Govardhan B; Harithakrishna R; Venkat Rao G; Pradeep R; Kunal B; Ramakrishna N; Anuradha S; Reddy DN
    Pancreatology; 2013; 13(3):267-72. PubMed ID: 23719599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The associations between serum VEGF, bFGF and endoglin levels with microvessel density and expression of proangiogenic factors in malignant and benign ovarian tumors.
    Szubert S; Moszynski R; Michalak S; Nowicki M; Sajdak S; Szpurek D
    Microvasc Res; 2016 Sep; 107():91-6. PubMed ID: 27312585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic polymorphisms in the Fas and FasL genes are associated with epithelial ovarian cancer risk and clinical outcomes.
    Li Y; Hao YL; Kang S; Zhou RM; Wang N; Qi BL
    Gynecol Oncol; 2013 Mar; 128(3):584-9. PubMed ID: 23234803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular endothelial growth factor expression correlates with serum CA125 and represents a useful tool in prediction of refractoriness to platinum-based chemotherapy and ascites formation in epithelial ovarian cancer.
    Masoumi-Moghaddam S; Amini A; Wei AQ; Robertson G; Morris DL
    Oncotarget; 2015 Sep; 6(29):28491-501. PubMed ID: 26143638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tyrosine kinase A receptor (trkA): a potential marker in epithelial ovarian cancer.
    Tapia V; Gabler F; Muñoz M; Yazigi R; Paredes A; Selman A; Vega M; Romero C
    Gynecol Oncol; 2011 Apr; 121(1):13-23. PubMed ID: 21236475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. nm23 gene polymorphisms are associated with survival of patients with epithelial ovarian cancer but not with susceptibility to disease.
    Li Y; Kang S; Qin JJ; Wang N; Zhou RM; Sun HY
    Gynecol Oncol; 2012 Sep; 126(3):455-9. PubMed ID: 22683585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Polymorphisms of ERCC1 gene and outcomes in epithelial ovarian cancer patients with platinum-based chemotherapy].
    Qi BL; Li Y; Wang N; Zhou RM; Hu P; Kang S
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):847-52. PubMed ID: 24444563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphisms in the CASP8 gene and the risk of epithelial ovarian cancer.
    Ma X; Zhang J; Liu S; Huang Y; Chen B; Wang D
    Gynecol Oncol; 2011 Sep; 122(3):554-9. PubMed ID: 21714991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Over-Expression of TBL1XR1 Indicates Poor Prognosis of Serous Epithelial Ovarian Cancer.
    Ma M; Yu N
    Tohoku J Exp Med; 2017 Mar; 241(3):239-247. PubMed ID: 28344213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic importance of vascular endothelial growth factor-A expression and vascular endothelial growth factor polymorphisms in epithelial ovarian cancer.
    Smerdel MP; Waldstrøm M; Brandslund I; Steffensen KD; Andersen RF; Jakobsen A
    Int J Gynecol Cancer; 2009 May; 19(4):578-84. PubMed ID: 19509553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum sErbB1 and epidermal growth factor levels as tumor biomarkers in women with stage III or IV epithelial ovarian cancer.
    Baron AT; Lafky JM; Boardman CH; Balasubramaniam S; Suman VJ; Podratz KC; Maihle NJ
    Cancer Epidemiol Biomarkers Prev; 1999 Feb; 8(2):129-37. PubMed ID: 10067810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.